HIMS & Her stock fell on Thursday as Tele-Pharmacy continued to drive out of the point home.‘T relies on selling a significant amount of Copycat Ozempic and Wegovy.
The federal judge made a favorable ruling on the food pharmacy late Wednesday. Ellie Lily. Complex pharmacies can only be sold if only the exact copies of the drug are insufficient.
He and her Ellie Lily’s active ingredient has never been sold.‘S drug. We sell a composite semi gluteide, an active ingredient Novo Nordic The weight loss drug Ozempic and WEGOVY said it will stop after May 2025.
The ruling insisted on the Trade Association (FDA) representing the benefits of the benefits in a lawsuit filed by the Outsourcing Secilities Association.‘Sudden order to stop rationalization Tir Jiper Side After being removed from the Lack of October “Reckless and arbitrary.‘ But OFA also filed a parallel lawsuit against the FDA. Semi -glutate From February 21st in a list of tribes.
Both cases suggested that before the Mark T. Pete Judge of the US District Court in the northern Texas region, OFA could obtain similar results regarding the semagluide. The ruling creates the hope that the judge can somehow allow him and her to continue selling Copycat Ozempic and Wegovy.
Since SEMAGLUTIDE has been out of a shortage, HIMS & HERS stocks have fallen more than 46%. Wednesday, Novo Nordisk announced that it would provide Wegovy at a discounted rate for patients who did not have insurance.
HIMS & She said that the future game plan is to sell old and less effective GLP-1 drugs and oral drugs by Novo Nordisk. Tele-Pharmacy sells other general medicines for erectile dysfunction, hair loss and mental health.
